Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)

• Main Authors: Norman Wasel (Author), Diamant Thaçi (Author), Lars E. French (Author), Curdin Conrad (Author), Yves Dutronc (Author), Gaia Gallo (Author), Lovisa Berggren (Author), Jean-Philippe Lacour (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Patients with plaque psoriasis often have nail psoriasis, which is difficult to treat. Ixekizumab (IXE) and ustekinumab (UST) are biologics with established efficacy in nail psoriasis. We present post hoc data from a head-to-head trial of IXE and UST (IXORA-S) to examine the ef...